![Tongle Yu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tongle Yu
Directeur/Membre du Conseil chez
Jiangsu Highlight Equity Investment Management Co. Ltd.
Profil
Tongle Yu is currently a Partner at Jiangsu Highlight Equity Investment Management Co. Ltd. Previously, he worked as a Non-Executive Director at Biosino Bio-Technology & Science, Inc. from 2013 to 2015.
He obtained his undergraduate degree from Fudan University.
Postes actifs de Tongle Yu
| Sociétés | Poste | Début |
|---|---|---|
Jiangsu Highlight Equity Investment Management Co. Ltd.
 Jiangsu Highlight Equity Investment Management Co. Ltd. Investment ManagersFinance Highlight Capital is an active asset manager that provides equity financing for early and growth stage capital requirements. The firm targets companies operating in the biopharmaceutical, medical technology and consumer health sectors. | Directeur/Membre du Conseil | - |
Anciens postes connus de Tongle Yu
| Sociétés | Poste | Fin |
|---|---|---|
| BIOSINO BIO-TECHNOLOGY AND SCIENCE INCORPORATION | Directeur/Membre du Conseil | 03/03/2015 |
Formation de Tongle Yu
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
16
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Biosino Bio-Technology & Science, Inc.
 Biosino Bio-Technology & Science, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes in-vitro diagnostic reagent | Health Technology |
Fudan University
 Fudan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jiangsu Highlight Equity Investment Management Co. Ltd.
Jiangsu Highlight Equity Investment Management Co. Ltd. Investment ManagersFinance Highlight Capital is an active asset manager that provides equity financing for early and growth stage capital requirements. The firm targets companies operating in the biopharmaceutical, medical technology and consumer health sectors. | Finance |
